GigaCloud proves the bears wrong by reporting a resilient double-digit growth profile in the EU. Read why GCT stock is ...

Verisk Analytics' recent slump aligns with an industry-wide downturn, as evidenced by similar trends in Moody's and Experian.

BeOne Medicines Q4 earnings and revenue beat the Street's expectations; the outlook missed by a small margin. Read why I have ...

Energy Fuels has surged nearly 400% since last April, outperforming uranium and rare earth peers. Read why I retain a hold ...

SCZ ETF review: diversification and 2025 gains vs a 0.40% expense ratio, Japan concentration and currency risk.

SPYD's equal weighting, sector diversification, and income orientation position it as a defensive core allocation amid ...

Acadia Pharmaceuticals' two approved drugs, NUPLAZID and DAYBUE are guided to continue their strong growth trajectories. Read why ACAD stock is a buy.

New Berkshire Hathaway CEO Greg Abel vows to uphold Buffett’s stewardship and values, and flags slower insurance growth in 2025—read the latest update now.

Omnicom Group offers compelling value at under 8x earnings, with a well-covered 3.5% yield and significant upside potential.

Track junk bond yields and spreads as leading signals for equity risk. Currently, junk bond yields (VWEHX ~6.18%) are below ...

Fidus Investment trades at a discount to NAV with resilient earnings and a $0.43 dividend covered by NII. See here for an ...

Momentum and liquidity support ECH, but above-average expenses and below-average yield challenge total returns. Check out why ...